Study Evaluating the Effects of Multiple Doses of NSA-789 in Subjects With Schizophrenia or Schizoaffective Disorder
Clinical trial NCT00892021 · WITHDRAWN
Trial details
- NCT number
- NCT00892021
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2009-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.